Cost-effectiveness of Evolocumab in Adult patients with atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective

W Xie, Y Song, X Qin, P Jin - Advances in Therapy, 2023 - Springer
Introduction To assess the cost-effectiveness of evolocumab with statins versus placebo
combined with statins in the treatment of adult patients with atherosclerotic cardiovascular …
被引用次数：2 相关文章

Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective.

W Xie, Y Song, X Qin, P Jin - Advances in Therapy, 2022 - europepmc.org
Methods A Markov model, based on data from the FOURIER trial, claims databases, and
published literature, was used to compare the health outcomes of the two therapies from the …

Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective

W Xie, Y Song, X Qin, P Jin - Advances in therapy, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction To assess the cost-effectiveness of evolocumab with statins versus placebo
combined with statins in the treatment of adult patients with atherosclerotic cardiovascular …